← All trials
NCT06607419
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 21, 2024
- Primary completion
- May 31, 2025
- Completion date
- May 31, 2030
- First posted
- Sep 23, 2024
- Last posted
- Sep 23, 2024
- Enrollment
- 90
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityLead sponsor
- Ningbo Women & Children's HospitalCollaborator
- Fujian Medical UniversityCollaborator
- Guizhou Medical UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
- Central South UniversityCollaborator
- Central South UniversityCollaborator
- Jiangxi Children's HospitalCollaborator
- Jiao Tong UniversitySponsor investigator
- Xiamen UniversityCollaborator
- Xiamen UniversityCollaborator
- Anhui Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.